| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 15 Jan 25 | VYNE VYNE Therapeutics | Common Stock | Buy | Acquire P | No | No | 2.92 | 15,000 | 43.80 k | 51,472 |
| 12 Dec 24 | VYNE VYNE Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.4 | 20,000 | 48.00 k | 20,000 |
| 1 Jan 24 | VYNE VYNE Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.33 | 20,000 | 46.60 k | 20,000 |
| 13 Dec 23 | VYNE VYNE Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.7 | 20,000 | 54.00 k | 20,000 |
| 15 Nov 23 | VYNE VYNE Therapeutics | Common Stock | Buy | Acquire P | No | No | 3.906 | 13,000 | 50.78 k | 36,472 |
